Maximum quantity allowed is 999
	  Please select the quantity
	
CAS RN: 119478-56-7 | Product Number: M2279
Meropenem Trihydrate
 
									 
							Purity: >98.0%(T)(HPLC)
Synonyms:
						
						Product Documents:
                    
				
						* Please contact our distributors or
						TCI
						to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
						* The storage conditions are subject to change without notice.
| Product Number | M2279 | 
| Purity / Analysis Method   | >98.0%(T)(HPLC) | 
| Molecular Formula / Molecular Weight | C__1__7H__2__5N__3O__5S·3H__2O = 437.51 | 
| Physical State (20 deg.C) | Solid | 
| Storage Temperature   | Refrigerated (0-10°C) | 
| Condition to Avoid | Heat Sensitive | 
| Packaging and Container   | 1G-Glass Bottle with Plastic Insert (View image) | 
| CAS RN | 119478-56-7 | 
| Related CAS RN   | 96036-03-2 | 
| PubChem Substance ID | 135727273 | 
| Merck Index (14) | 5900 | 
| MDL Number | MFCD08600005 | 
Specifications
		  | Appearance | White to Light yellow powder to crystal | 
| Purity(HPLC) | min. 98.0 area% | 
| Purity(Neutralization titration) | min. 98.0 % | 
| Specific rotation [a]20/D | -17.0 to -21.0 deg(C=0.44, H2O) | 
| Water | 11.4 to 13.4 % | 
		Properties (reference)
	| Specific Rotation | -18° (C=0.44,H2O) | 
| Solubility in water | Soluble | 
 
						 GHS
						  
								 Related Laws: 
							   | RTECS# | CL5446507 | 
 
						Transport Information:
							| H.S.code* | 2941.90-000 | 
			Application
		
			Meropenem: A Carbapenem Antibiotic with Broad Spectrum of Activity and Stability to β-Lactamases
		
		Meropenem, which is the second carbapenem antibiotic, has a broad spectrum of activity that includes activity against gram-positive bacteria and excellent gram-negative aerobic and anaerobic activity. It has enhanced gram-negative activity relative to imipenem (the first carbapenem antibiotic)-cilastatin and often retains activity against strains resistant to third-generation cephalosporins and imipenem-cilastatin. It has increased stability to β-lactamases compared with imipenem.
References
- Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
- Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems- T. Köhler, M. Michea-Hamzehpour, S. F. Epp, J.-C. Pechere, Antimicrob. Agents Chemother. 1999, 43, 424.
 
- Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
- Comparative review of the carbapenems
- Meropenem: a review of its use in the treatment of serious bacterial infections
			PubMed Literature
		Documents
Product Articles
  		        Product Documents (Note: Some products will not have analytical charts available.)
 		Safety Data Sheet (SDS)
                	  
                      
						Please select Language.
		         
                 
        			
					The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
				     
						
						
						
							Please enter Lot Number
						
							Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
                        
				
                
	         	
                
                
    		Sample C of A
                    This is a sample C of A and may not represent a recently manufactured lot of the product.
	         	
                A sample C of A for this product is not available at this time.
Analytical Charts
					 
			  
		  
                                			
                                				        
                                						
                                						
                                						
                                							Please enter Lot Number
                                						
                                							Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
                                						
                                				
                                				
                                	         	
                                                
                                                    The requested analytical chart is not available. Sorry for the inconvenience.

 
       
                                 
	